Note On Importance of Correct Stoichiometric Assumptions for Modeling of Monoclonal Antibodies

Author:

Gibiansky Leonid1,Gibiansky Ekaterina1

Affiliation:

1. QuantPharm LLC

Abstract

Abstract Modeling of monoclonal antibodies with non-linear binding is based on equations of the target-mediated drug disposition (Mager and Jusko, 2001). These equations demonstrated their utility for modeling monoclonal antibodies (mABs) in countless examples and drug development programs. The model assumes that the drug and the target have only one binding site each while most antibodies have two binding sites. We investigated, using simulations, whether this discrepancy is important and when it is advisable to use a model with correct stoichiometric 2-to-1 ratio. It was shown that for soluble targets when elimination rate of the drug-target complex is comparable with the elimination rate of the drug or lower, and when measurements of both total drug and total target concentrations are available, the model with 1-to-1 binding cannot describe data simulated from the model with 2-to-1 binding. In these cases, models with correct stoichiometric assumptions may be necessary for an adequate description of the observed data. Also, a model with allosteric binding that encompasses both 2-to-1 and 1-to-1 binding models as particular cases was proposed and applied. It was shown to be identifiable given the detailed concentration data of total drug and total target.

Publisher

Research Square Platform LLC

Reference5 articles.

1. General pharmacokinetic model for drugs exhibiting target-mediated drug disposition;Mager DE;J Pharmacokinet Pharmacodyn,2001

2. Quasi-equilibrium pharmacokinetic model for drugs exhibiting target-mediated drug disposition;Mager DE;Pharm Res,2005

3. Approximations of the target-mediated drug disposition model and identifiability of model parameters;Gibiansky L;J Pharmacokinet Pharmacodyn,2008

4. Target-mediated drug disposition model for drugs with two binding sites that bind to a target with one binding site;Gibiansky L;J Pharmacokinet Pharmacodyn,2017

5. Beal SL, Sheiner LB, Boeckmann AJ, Bauer R (eds) (1989–2021) NONMEM Users Guides. Icon Development Solutions, Ellicott City, MD, USA

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3